We are live on ! Find out more
LAB icon

Standard BioTools
LAB

131 hedge funds and large institutions have $854M invested in Standard BioTools in 2019 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 60 increasing their positions, 17 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

655% more call options, than puts

Call options by funds: $302K | Put options by funds: $40K

253% more repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 17

213% more first-time investments, than exits

New positions opened: 47 | Existing positions closed: 15

103% more capital invested

Capital invested by funds: $422M → $854M (+$433M)

32% more funds holding

Funds holding: 99 → 131 (+32)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

8.31% less ownership

Funds ownership: 101.5% → 93.19% (-8.3%)

Holders
131
Holders Change
+32
Holders Change %
+32.32%
% of All Funds
2.84%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
47
Increased
60
Reduced
17
Closed
15
Calls
$302K
Puts
$40K
Net Calls
+$262K
Net Calls Change
-$9K

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$19.2M
2
PHS
PFM Health Sciences
California
+$15.2M
3
RI
RTW Investments
New York
+$11M
4
Deutsche Bank
Deutsche Bank
Germany
+$10.8M
5
Renaissance Technologies
Renaissance Technologies
New York
+$9.64M

Top Sellers

1
LCS
Levin Capital Strategies
New York
-$98.9M
2
HVC
Healthcare Value Capital
New Jersey
-$3.88M
3
ICM
Indaba Capital Management
California
-$3.45M
4
PVI
Pura Vida Investments
New York
-$2.73M
5
Neuberger Berman Group
Neuberger Berman Group
New York
-$2.64M
Name Holding Trade Value Shares
Change 		Change in
Stake
Northern Trust
26
Northern Trust
Illinois
$6.52M +$1,000K +94,825 +24%
TA
27
Teachers Advisors
New York
$6.42M +$4.5M +426,900 +758%
PAM
28
Panagora Asset Management
Massachusetts
$6.06M +$374K +35,446 +8%
PVI
29
Pura Vida Investments
New York
$5.58M -$2.73M -258,596 -38%
Allianz Asset Management
30
Allianz Asset Management
Germany
$5.55M +$4.41M +417,948 New
Schroder Investment Management Group
31
Schroder Investment Management Group
United Kingdom
$5.33M -$1.06M -100,555 -20%
EI
32
EAM Investors
California
$5.14M +$1.58M +149,767 +63%
KCM
33
Kennedy Capital Management
Missouri
$4.9M -$330K -31,304 -8%
Invesco
34
Invesco
Georgia
$4.57M +$1.17M +110,609 +47%
Norges Bank
35
Norges Bank
Norway
$4.5M +$781K +74,128 +28%
PCM
36
Perkins Capital Management
Minnesota
$4.4M +$66.9K +6,350 +2%
OAM
37
Oxford Asset Management
United Kingdom
$4.32M +$653K +61,975 +24%
NCGI
38
Next Century Growth Investors
Minnesota
$3.88M +$3.08M +291,893 New
Jacobs Levy Equity Management
39
Jacobs Levy Equity Management
New Jersey
$3.75M +$549K +52,100 +23%
Artisan Partners
40
Artisan Partners
Wisconsin
$3.44M +$2.73M +258,626 New
CM
41
Castleark Management
Illinois
$3.23M +$2.57M +243,382 New
Wells Fargo
42
Wells Fargo
California
$3.17M +$2.23M +211,926 +799%
Fuller & Thaler Asset Management
43
Fuller & Thaler Asset Management
California
$2.99M +$39K +3,700 +2%
Goldman Sachs
44
Goldman Sachs
New York
$2.91M +$1.9M +180,130 +461%
AQR Capital Management
45
AQR Capital Management
Connecticut
$2.86M +$2M +190,189 +757%
CEP
46
Chicago Equity Partners
Illinois
$2.73M +$1.79M +169,460 +467%
AC
47
Alexandria Capital
Virginia
$2.51M – – –
BIM
48
Bogle Investment Management
Massachusetts
$2.5M +$1.98M +188,208 New
RA
49
Royce & Associates
New York
$2.46M +$390K +37,000 +25%
LCS
50
Levin Capital Strategies
New York
$2.4M -$98.9M -9,386,212 -98%
1
2
3 4 5

LAB Hedge Fund Activity: Q1 2019 in Review

131 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q1 2019, worth a combined $854M — up 103% from $422M a quarter earlier.

Buyers outnumbered sellers: 47 funds opened new LAB positions and 15 closed out — a net gain of 32 holders — while 60 added to existing stakes and 17 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $19.2M. The largest seller was Levin Capital Strategies, cutting an estimated $98.9M.

  • 131 institutional investors held Standard BioTools (LAB) as of Q1 2019, up from 99 in Q4 2018.
  • Funds reported $854M of Standard BioTools stock for Q1 2019, up 103% quarter-over-quarter.
  • 47 funds opened new Standard BioTools positions in Q1 2019 and 15 closed out, a net change of +32 holders.
  • The largest Standard BioTools buyer in Q1 2019 was Fidelity Investments, an estimated $19.2M added.
  • The largest Standard BioTools seller in Q1 2019 was Levin Capital Strategies, an estimated $98.9M sold.

Based on aggregated 13F filings for Q1 2019.